SAKAR HEALTHCARE
Back to Income Statement
|
SAKAR HEALTHCARE Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹115 Cr | ₹100 Cr | ₹99 Cr | ₹72 Cr | ₹6,343,119 Cr |
What is the latest Total Expenditure of SAKAR HEALTHCARE ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹115 Cr |
| Mar2024 | ₹100 Cr |
| Mar2023 | ₹99 Cr |
| Mar2022 | ₹72 Cr |
| Mar2021 | ₹6,343,119 Cr |
How is Total Expenditure of SAKAR HEALTHCARE Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹115 Cr | 14.86 | |
| Mar2024 | ₹100 Cr | 1.22 | |
| Mar2023 | ₹99 Cr | 37.10 | |
| Mar2022 | ₹72 Cr | -100.00 | |
| Mar2021 | ₹6,343,119 Cr | - | |
Compare Total Expenditure of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹2,117.3 Cr | -1.2% | 9.7% | 169.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.4% | 0.9% | 19.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | -1.2% | 21.1% | 29.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.3% | 0.3% | 34.8% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.7% | 1.5% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | -0.3% | -7.1% | -3.9% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -1.2% |
9.7% |
169.7% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses